Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2307
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms ; day:23 ; month:6 ; year:2021 ; pages:1-8
Virchows Archiv ; (23.6.2021), 1-8
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-021-03129-y
- URN
-
urn:nbn:de:101:1-2021100912455127174265
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Person, Fermin
- Meyer, Sara C.
- Hopfer, Helmut
- Menter, Thomas
- SpringerLink (Online service)
Other Objects (12)
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms